Ignite Creation Date:
2025-12-24 @ 2:17 PM
Ignite Modification Date:
2026-01-29 @ 2:00 AM
Study NCT ID:
NCT03646695
Status:
COMPLETED
Last Update Posted:
2021-08-24
First Post:
2018-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study
Sponsor:
Vienna Institute for Research in Ocular Surgery
Organization:
Study Overview
Official Title:
ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study
Status:
COMPLETED
Status Verified Date:
2021-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients with macular hole \<400µm will be randomized for ILM flap Transposition and ILM Peeling for surgical repair of macular holes
Detailed Description:
Patients with macular hole with a diameter larger than 400µm have better sucess with ILM flap transposition, but there are no data published examining the outcome of macular hole with a diameter \<400µm. Therefore, patients with macular hole with a diameter \<400µm will be randomized for ILM flap transposition and ILM peeling for surgical repair of macular holes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: